Ausgabe 6/2024
Inhalt (6 Artikel)
Sex Differences in Adverse Effects of Antiseizure Medications in Adults with Epilepsy: A Systematic Review
Loretta Giuliano, Vania Durante, Giulia Battaglia, Sara Gasparini, Elena Zambrelli, Caterina Ermio, Angela La Neve, Barbara Mostacci
FcRn Inhibitor Therapies in Neurologic Diseases
Nouf Alfaidi, Salama Karmastaji, Alexandria Matic, Vera Bril
Impulse Control Disorders in Parkinson’s Disease: An Overview of Risk Factors, Pathogenesis and Pharmacological Management
Federico Carbone, Atbin Djamshidian
Post-COVID Trajectory of Pentraxin 3 Plasma Levels Over 6 Months and Their Association with the Risk of Developing Post-Acute Depression and Anxiety
Rebecca De Lorenzo, Mario G. Mazza, Clara Sciorati, Roberto Leone, Francesco Scavello, Mariagrazia Palladini, Aurora Merolla, Fabio Ciceri, Barbara Bottazzi, Cecilia Garlanda, Francesco Benedetti, Patrizia Rovere-Querini, Angelo A. Manfredi
Rapid Metabolism Underlying Subtherapeutic Serum Levels of Atypical Antipsychotics Preceding Clozapine Treatment: A Retrospective Analysis of Real-World Data
Hasan Çağın Lenk, Robert Løvsletten Smith, Kevin S. O’Connell, Ole A. Andreassen, Espen Molden
Synergism of Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA in the Treatment of Chronic Migraine: A Real-World Retrospective Chart Review
Amira Salim, Elise Hennessy, Claire Sonneborn, Olivia Hogue, Sudipa Biswas, MaryAnn Mays, Aarushi Suneja, Zubair Ahmed, Ignacio F. Mata